Evox has been granted US Patent US11,640,272. The claims of this patent cover a method of purifying engineered exosomes via a downstream process utilizing ultrafiltration and size-based separation...
Read More »ExoCoBio granted first plant stem cell-derived exosome patent in the US
ExoCoBio announced that it has obtained a patent (US Application No: 17/141,693) from the US Patent and Trademark Office for a cosmetic composition...
Read More »NurExone granted US patent for technology and drug composition of Exo-PTEN, designed for treating acute spinal cord injuries
NurExone Biologic Inc, a biopharmaceutical company developing biologically-guided exosome therapy for patients with traumatic spinal cord injuries, announces that the Company has received an issue...
Read More »USPTO allows patent to exosome biomedical company Nurexone
The patent covers Nurexone’s ExoPTEN drug compositions and treatment methods for Central Nervous System disease NurExone Biologic Inc, a biopharmaceutical company developing biologically...
Read More »Evox Therapeutics Expands its Exosome Manufacturing Patent Portfolio
Evox Therapeutics, a leading exosome therapeutics company, today announced that the Company has been granted four new patents covering a broad...
Read More »ExoCoBio Receives Japanese Patent for Alleviating Dermatitis with Adipose Stem Cell-Derived Exosome
ExoCoBio, one of global top 4 for stem cell exosome industry, announced that it received from Japanese Patent Office the patent which claims that stem cell-derived exosome is proved as effective ingredient for...
Read More »First Patent Regarding RPIDD Infectious Disease Liquid Biopsy Technology DNA Library Preparation and Amplification Methods Granted
Aptorum Group Limited, a clinical-stage biopharmaceutical company, is pleased to announce that the US Patent and Trademark Office (“US PTO”) has granted the patent regarding the Rapid Pathogen Infectious Disease Liquid Biopsy Diagnostics...
Read More »Evox Therapeutics Expands Its Exosome Patent Portfolio
Newly issued patent covers proprietary approach for loading nucleic acids into exosomes Evox Therapeutics, a leading exosome therapeutics company, today announced that the Company has...
Read More »EDGC applies for liquid biopsy cancer detection technology patent
A Korean genetic sequencing firm has taken a step towards the commercialization of its liquid biopsy technology, which aims at detecting early stage cancer with a simple blood test and suggesting optimized treatment. Eone Diagnomics Genome Center (EDGC) announced that ...
Read More »Creative Medical Technology Holdings Files Provisional Patent on Novel Type 1 Diabetes Immunotherapy Using Exosomes from MyeloCelz™ Platform
Creative Medical Technology Holdings announced today filing a new patent application covering nanoparticles called “exosomes” secreted by cells of its...
Read More »